The driving factors for this growth include development of new forms of oral dosage coupled with continuous
efforts toward providing compliant and superior products. The other factors include increasing incidences of
neurological diseases, cardiovascular diseases, and the other related diseases. The Asia Pacific region is forecast
to grow at the highest CAGR. This will be due to rising expenditure on the healthcare products and growing
healthcare awareness, increasing healthcare infrastructure and outsourcing of excipient manufacturing to Asian
countries, for example: China and India.
This growth in the market is expected due to the rising population of elderly people, pediatric patients, the
growing market for the generic drugs, and arrival of the new superdisintegrant materials. Yet there are certain
factors which will restrict the growth of this market, for example the expenditure on the research and
development is going down.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/superdisintegrants-market
Market Segmentation
Product Outlook (Revenue, USD Million, 2014 - 2025)
• Croscarmellose sodium
• Crospovidone
• Sodium starch glycolate
• Ion exchange resin
• Others
Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)
• Tablets and Capsules
• Mouth-dissolving Films
Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China